by Team Small News | Sep 29, 2025 | Aurobindo Pharma, Pharma, Sun Pharma, Zydus
Sun Pharma, Zydus, and three other pharmaceutical companies have issued recalls for their products in the US market. The recalls were initiated due to various reasons, including contamination, labeling issues, and deviations from manufacturing standards. Sun Pharma,... by Team Small News | Sep 20, 2025 | Aurobindo Pharma, Pharma
Aurobindo Pharma, a prominent pharmaceutical company, has reported a fire incident at its wholly-owned subsidiary, APL Healthcare Ltd, located in Naidupeta, Andhra Pradesh. The fire occurred in the granulation area-10 of Unit-IV, a Special Economic Zone (SEZ) unit,... by Team Small News | Sep 19, 2025 | Aurobindo Pharma, Pharma
Aurobindo Pharma is a pharmaceutical company that focuses on the research, development, manufacturing, and marketing of active pharmaceutical ingredients and generic pharmaceuticals. The company’s products can be categorized into two main families: generic drugs...
by Team Small News | Sep 14, 2025 | Aurobindo Pharma, Biocon, Cipla, Glenmark, Lupin, Mankind, Pharma, Sun Pharma, Torrent Pharma, Zydus
The pharmaceutical industry is complex, with various segments such as innovator products, generics, branded generics, and API. Indian companies are making headway globally, and understanding the industry’s intricacies is crucial for those seeking opportunities.... by Team Small News | Sep 7, 2025 | Aurobindo Pharma, Pharma
Aurobindo Pharma, a prominent pharmaceutical company, recently underwent a USFDA (United States Food and Drug Administration) inspection at its Unit-XII facility. The inspection resulted in the issuance of 8 observations, which are essentially a list of deficiencies... by Team Small News | Sep 6, 2025 | Aurobindo Pharma, Pharma
The US Food and Drug Administration (FDA) recently conducted an inspection of a manufacturing facility in India. The facility, known as Unit-XII, is owned by a Hyderabad-based drug firm and is located in Bachupally, Telangana. The inspection took place from August 25...